Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia

OBJECTIVE: To evaluate the efficacy and safety of add-on therapy with the phosphodiesterase type 5 inhibitor tadalafil in Japanese men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with dutasteride. RESULTS: Twenty-four patients were enrolled. The partici...

Descripción completa

Detalles Bibliográficos
Autores principales: Gotoh, Daisuke, Torimoto, Kazumasa, Morizawa, Yosuke, Hori, Shunta, Nakai, Yasushi, Miyake, Makito, Fujimoto, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446813/
https://www.ncbi.nlm.nih.gov/pubmed/36064733
http://dx.doi.org/10.1186/s13104-022-06183-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446813/
https://www.ncbi.nlm.nih.gov/pubmed/36064733
http://dx.doi.org/10.1186/s13104-022-06183-0

Ejemplares similares